Genasys financials
$1.47+1.38%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Sep 30 | FY24 Sep 30 | FY23 Sep 30 | FY22 Sep 30 | FY21 Sep 30 | FY20 Sep 30 |
|---|---|---|---|---|---|---|
| Revenue | $40.8M | $24.0M | $46.7M | $54.0M | $47.0M | $43.0M |
| Gross profit | $17.0M | $10.2M | $21.8M | $27.3M | $23.4M | $22.6M |
| Gross margin | 41.6% | 42.4% | 46.6% | 50.5% | 49.8% | 52.6% |
| Operating income | -$16.8M | -$26.7M | -$11.0M | -$15.5M | $1.1M | $6.0M |
| Net income | -$18.1M | -$31.7M | -$18.4M | -$16.2M | $704.0K | $11.9M |
| Net margin | −44.4% | −132.2% | −39.4% | −30.0% | 1.5% | 27.6% |
| Diluted EPS | $-0.40 | $-0.72 | $-0.50 | $-0.44 | $0.02 | $0.35 |
| EBITDA | -$14.0M | -$23.8M | -$8.4M | $933.0K | $2.7M | $6.8M |
| Operating cash flow | -$8.8M | -$19.5M | -$9.6M | $468.0K | $6.2M | $6.9M |
| Free cash flow | -$9.0M | -$19.6M | -$9.8M | $87.0K | $5.9M | $6.8M |
| Diluted shares | 45.1M | 44.3M | 36.9M | 36.5M | 35.6M | 34.1M |
Balance sheet
| Period end | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.0M | $4.9M | $8.7M | $12.7M | $13.2M | $23.3M |
| Short-term investments | $70.0K | $7.9M | $1.5M | $6.4M | $5.7M | $4.3M |
| Total debt | $18.0M | $12.0M | $0.00 | $0.00 | $296.0K | $318.0K |
| Total assets | $63.9M | $53.9M | $49.9M | $71.9M | $90.1M | $66.2M |
| Total liabilities | $61.7M | $36.4M | $16.1M | $21.5M | $24.2M | $17.0M |
| Shareholders' equity | $2.2M | $17.6M | $33.8M | $50.4M | $66.0M | $49.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology